5,702 Shares in Enhabit, Inc. (NYSE:EHAB) Purchased by Quantbot Technologies LP

Quantbot Technologies LP bought a new stake in shares of Enhabit, Inc. (NYSE:EHAB) during the 4th quarter, HoldingsChannel reports. The firm bought 5,702 shares of the company’s stock, valued at approximately $45,000.

Several other institutional investors and hedge funds also recently bought and sold shares of EHAB. Franklin Resources Inc. boosted its holdings in shares of Enhabit by 19.6% during the third quarter. Franklin Resources Inc. now owns 32,382 shares of the company’s stock worth $256,000 after purchasing an additional 5,317 shares during the period. JPMorgan Chase & Co. lifted its position in Enhabit by 37.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company’s stock worth $2,411,000 after buying an additional 83,707 shares in the last quarter. Paradice Investment Management LLC boosted its stake in shares of Enhabit by 12.8% during the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company’s stock valued at $13,903,000 after buying an additional 201,997 shares during the period. Systematic Financial Management LP grew its holdings in shares of Enhabit by 12.2% during the 3rd quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock valued at $14,522,000 after acquiring an additional 199,235 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new position in shares of Enhabit in the third quarter worth $215,000.

Enhabit Price Performance

Shares of EHAB opened at $8.72 on Wednesday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The firm has a market cap of $440.34 million, a PE ratio of -3.76 and a beta of 1.80. The firm’s 50 day moving average price is $8.54 and its 200 day moving average price is $7.99. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $11.35.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reissued a “buy” rating on shares of Enhabit in a research report on Thursday, March 6th.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.